Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A0SK
|
|||
| Former ID |
DIB014336
|
|||
| Drug Name |
HPH-116
|
|||
| Synonyms |
Azocarbonamide; Azodicarbonamide; ADA, Hubriphar; Azodicarbonamide, H-Phar
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 2 | [1] | |
| Company |
H-Phar Co
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Nucleocapsid p7 (HIV p7) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005689) | |||
| REF 2 | Clinical pipeline report, company report or official report of H-Phar. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.